Skip to main content
. 2017 Feb 24;49(1):22–30. doi: 10.3947/ic.2017.49.1.22

Table 3. Comparison of the clinical features of the CA-APN patients with positive and negative blood cultures.

Clinical characteristics Positive
Blood culture (N = 277)
n (%)
Negative
Blood culture (N = 371)
n (%)
P-value
Age≥70 years 111 (40.1) 80 (21.6) <0.001
Past history
 History of urinary tract infection within 1 years 64/231(27.7) 100/341(29.3) 0.674
 History of admission within 1 year 81/256 (31.6) 72/345 (20.9) 0.003
 History of antibiotics use within 1 year 69/217 (31.8) 117/323 (36.2) 0.289
Co-morbidities
 Charlson comorbidity index ≥1 151 (54.5) 117 (31.5) <0.001
 Diabetes mellitus 98 (35.4) 81 (21.8) <0.001
 Chronic renal disease 25 (9.0) 12 (3.2) 0.002
Clinical features
 Pitt score ≥1a 129 (46.6) 105 (28.3) <0.001
 Flank pain 69 (24.9) 97 (26.1) 0.721
 Symptom of lower urinary tract infection 164 (59.2) 249 (67.1) 0.038
 Costovertebral angle tenderness 164 (59.2) 242 (65.2) 0.117
Laboratory findings
 WBC≥20,000/mm3 36 (13) 24 (6.5) 0.005
 CRP≥20 mg/dL 100(36.1) 93 (25.1) 0.002
Clinical outcomes
 Discordant therapyb 22 (7.9) 20 (5.4) 0.192
 Duration of hospitalization (days, mean ± SD) 10.8 ± 7.2 8.1 ± 5.4 <0.001
 Defervescence time (days, mean ± SD) 3.2 ± 2.9 2.1 ± 2.5 0.014
 Hospital mortality 9/251 (3.6) 1/338 (0.3) 0.003
 Final clinical failure 20/251 (8.0) 9/338 (2.7) 0.003

a See method for calculation of Pitt scores.

bDiscordant therapy was defined as cases whose empirical antimicrobial therapy regimen was changed due to the drug resistance.

CA-APN, community-acquired acute pyelonephritis, WBC, white blood cell; CRP, C-reative protein; SD, standard deviation.